COMPASS Pathways Plc (CMPS)

factsheet Factsheet
  • Market Capitalisation market-capitalisation-info $360 Mln
  • Price to Earnings Ratio price-to-earning --
  • 12 Month Earnings monthly-earning $-39 Mln

COMPASS Pathways Plc (CMPS) Share Price

$6.10

As on 04-Dec-2023 16:00 EST

$0.000.00%

  • Prev Close info

    $6.10

  • Day's Openinfo

    $6.03

  • Today's Highinfo

    $6.28

  • Today's Lowinfo

    $5.74

  • Today's Volumeinfo

    473,760

  • 52 Week rangeinfo

    $5.01 - 11.48

Please wait...

COMPASS Pathways Plc (CMPS) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
COMPASS Pathways (CMPS)
-24.03 -4.84 -34.62 -45.58 -51.50 -- --
S&P BSE Sensex*
13.75 7.53 5.46 10.08 15.36 13.88 12.82
S&P BSE Healthcare#
32.48 9.92 9.75 27.53 13.31 16.60 12.24
As on 04-Dec-2023  |  *As on 05-Dec-2023  |  #As on 05-Dec-2023
2022
2021
COMPASS Pathways (CMPS)
-63.67 -53.61
S&P BSE Sensex
4.44 21.99
S&P BSE Healthcare
-12.10 20.87

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

COMPASS Pathways Plc (CMPS) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of COMPASS Pathways Plc (CMPS)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other details of COMPASS Pathways Plc (CMPS)

        Exec. Chairman & Co-Founder

        Mr. George Jay Goldsmith

        Co-Founder, Chief Innovation Officer & Exec. Director

        Dr. Ekaterina Malievskaia M.D.

        Headquarters

        London

        FAQs for COMPASS Pathways Plc (CMPS)

        The total asset value of COMPASS Pathways Plc (CMPS) stood at $ 185 Mln as on 31-Mar-23

        The share price of COMPASS Pathways Plc (CMPS) is $6.10 (NASDAQ) as of 04-Dec-2023 16:00 EST. COMPASS Pathways Plc (CMPS) has given a return of -51.5% in the last 3 years.

        COMPASS Pathways Plc (CMPS) has a market capitalisation of $ 360 Mln as on 02-Jun-2023. As per Value Research classification, it is a company.

        The P/B ratio of COMPASS Pathways Plc (CMPS) is 2.18 times as on 02-Jun-2023, a -0.18% premium to its peers’ median range of 2.67 times.

        Since, TTM earnings of COMPASS Pathways Plc (CMPS) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the COMPASS Pathways Plc (CMPS) and enter the required number of quantities and click on buy to purchase the shares of COMPASS Pathways Plc (CMPS).

        COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

        The CEO & director of Mr. George Jay Goldsmith. is COMPASS Pathways Plc (CMPS), and CFO & Sr. VP is Dr. Ekaterina Malievskaia M.D..

        The promoters of COMPASS Pathways Plc (CMPS) have pledged 0% of the total equity as on Mar-23.

        COMPASS Pathways Plc (CMPS) Ratios
        Return on equity(%)
        -53.08
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0
        Dividend yield(%)
        0

        No, TTM profit after tax of COMPASS Pathways Plc (CMPS) was $-39 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $359.50 Mln
        • Revenue (TTM)revenue-information $0.00 Mln
        • Earnings (TTM) earning-information $-39.41 Mln
        • Cash date-information $117.10 Mln
        • Total Debt info $1.52 Mln
        • Insider's Holding 45.43%
        • Liquidity liquidity High
        • 52 Week range week-range $5.01 - 11.48
        • Shares outstanding share-outstanding 45,621,700
        • 5 Years Aggregate:

          CFO: $-242.19 Mln

          EBITDA: $-239.39 Mln

          Net Profit: $-256.41 Mln

        About The Company

        • IPO Date 18-Sep-2020
        • Exec. Chairman & Co-Founder Mr. George Jay Goldsmith
        • Co-Founder, Chief Innovation Officer & Exec. Director Dr. Ekaterina Malievskaia M.D.
        • Listing key-listing NASDAQ: CMPS
        • Country United Kingdom
        • Headquarters headquarters London
        • Website website https://compasspathways.com
        • Business

          COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression;...  and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        share-fund-plan-icon